Nanomedicine: An International Glimpse

Journal of Experimental and Clinical Medicine

Volumn 3, Issue 3, 2011, Pages 101-103

  Cooper, Edwin L ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA CYCLODEXTRIN; FULLERENE DERIVATIVE; LIPOPOLYSACCHARIDE; NANOPARTICLE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; ZINC OXIDE;

BIOMEDICINE; CANCER CELL DESTRUCTION; CELL VIABILITY; CYTOTOXICITY; DISSOLUTION; DRUG DELIVERY SYSTEM; EDITORIAL; ENZYME INHIBITION; FLUORESCENCE IMAGING; GENE EXPRESSION; HUMAN; NANOMEDICINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 79958828809     PISSN: 18783317     EISSN: 18783325     Source Type: Journal    
DOI: 10.1016/j.jecm.2011.04.009     Document Type: Editorial

References (12)

1. Ratner M.A., Ratner D. Nanotechnology: A Gentle Introduction to the Next Big Idea 2002, Prentice Hall, New Jersey.
2. Nel A., Xia T., Maedler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
3. Xia T., Zhao Y., Sager T., George S., Pokhrel S., Li N., Schoenfeld D., et al. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano 2011, 5:1223-1235.
4. Nel A.E., Mädler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., Klaessig F., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8:543-557.
5. Meng H., Liong M., Xia T., Li Z., Ji Z., Zink J.I., Nel A.E. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and Pgp siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010, 8:4539-4550.
6. Meng H., Xue M., Tian Xia T., Zhao Y.L., Fuyuhiko Tamanoi F., Fraser Stoddart J.F., Zink J.I., et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J Am Chem Soc 2010, 132:12690-12697.
7. Klichko Y., Liong M., Choi E., Angelos S., Nel A.E., Stoddart J.F.S., Fuyuhiko Tamanoi F., et al. Mesostructured silica for optical functionality, nanomachines amd drug delivery. J Am Ceram Soc 2009, 92:S2-S10.
8. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., Tamanoi F., et al. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery. ACS Nano 2008, 2:889-896.
9. Lee C.M., Huang S.T., Huang S.H., Lin H.W., Tsai H.P., Wu J.Y., Lin C.M., et al. C60 Fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide. Nanomedicine Nanotechnol Biol Med 2011, 7:107-114.
10. Huang S.T., Ho C.S., Lin C.M., Fang H.W., Peng Y.X. Development and biological evaluation of C(60) fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent. Bioorg Med Chem 2008, 16:8619-8626.
11. Huang S.T., Liao J.S., Fang H.W., Lin C.M. Synthesis and anti-inflammation evaluation of new C60 fulleropyrrolidines bearing biologically active xanthine. Bioorg Med Chem Lett 2008, 18:99-103.
12. Lu T.Y., Kao P.F., Lee C.M., Huang S.T., Lin C.M. C60 Fullerene Nanoparticle Prevents the β-Amyloid Peptide Induced Cytotoxicity in Neuro 2A Cells. J Food Drug Anal 2011, 19:1-8.